← SynDRA
LEUCINE
SynDRA canonical compound SYN0002617 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | BCAT1 | BCAT2 | LARS | LARS2 | LCMT1 | LCMT2 |
|---|
All known targets
- BCAT1
- BCAT2
- LARS
- LARS2
- LCMT1
- LCMT2
- SLC7A5
Cross-references
Synonyms
- L-Leucine
- Leu
- E641
- Leucina
- L-leucine
- Leucine, l
- FEMA NO. 3297
- NSC-46709
- (S)-2-Amino-4-methylpentanoic acid
- H-Leu-OH
- (S)-Leucine
- (2S)-2-amino-4-methylpentanoic acid
- (S)-(+)-Leucine
- Leucin
- L-Norvaline, 4-methyl-
- (S)-2-Amino-4-methylvaleric acid
- L-leucin
- L-alpha-Aminoisocaproic acid
- Leucin [German]
- LEUCINE, L-
- Leucine (VAN)
- leu
- Leucinum
- (2S)-alpha-leucine
- L-(-)-2-Amino-4-methylpentanoic acid
- 2-amino-4-methylvaleric acid
- Leucinum [INN-Latin]
- Leucine [USAN:INN]
- L-Leuzin
- Leucina [INN-Spanish]
- Leucina [Latin,Spanish]
- alpha-Aminoisocaproic acid
- leucine (ii)
- lysine hydrochloride impurity a (ep impurity)
- GMW67QNF9C
- FEMA No. 3297
- leucine (usp monograph)
- NSC 46709
Reported adverse events
- Electrolyte imbalance
- Hypersensitivity
- Infection
- Pulmonary embolism
- Refeeding syndrome
- Alkalosis
- Extravasation
- Glycosuria
- Local reaction
- Metabolic acidosis
- Death
- Sepsis
Look up LEUCINE in the interactive SynDRA portal →